Hosted on MSN

Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTD

Shares of pharmaceutical company Aurobindo Pharma rose over 3% in trade on Monday, August 31, after the company announced that its subsidiary had launched a product in the US market. Following the ...
Morningstar%2c Inc.

Cipla Receives U.S. FDA Approval for Generic Advair Diskus®

MUMBAI, India and WARREN, N.J., July 28, 2026 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") and its wholly owned subsidiary Cipla USA Inc., ...
RAPS

Mylan Wins FDA Approval for First Advair Generic

The US Food and Drug Administration (FDA) late Wednesday approved the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the ...
Drug Store News

Cipla receives FDA nod for generic Advair Diskus

The FDA approval spans all three strengths of generic Advair Diskus. Gupta added, "This approval reinforces our commitment to expanding access to complex therapies in the United States and highlights ...
moneycontrol.com

Cipla rises 2.7% after USFDA approval for generic Advair; Nomura sees sales upside

The brokerage noted that Cipla has received approval for all three strengths of generic Advair Diskus, marking ‘the first dry powder inhaler approval for Cipla.’ Cipla shares rose over 2.5% in ...
Medical Xpress

Generic fluticasone-salmeterol as effective as brand-name version, study finds

A propensity score-matched cohort study of patients treated for chronic obstructive pulmonary disease (COPD) in routine practice found that the use of generic and brand-name fluticasone–salmeterol was ...